Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
173.2 SEK | +0.35% | +2.49% | +15.16% |
Apr. 25 | Transcript : Pandox AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Pandox AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company appears to be poorly valued given its net asset value.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- One of the major weak points of the company is its financial situation.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Real Estate Development & Operations
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.16% | 2.95B | B | ||
+40.41% | 29.66B | B- | ||
-11.60% | 27.69B | B | ||
+7.86% | 27.57B | B- | ||
+20.90% | 26.07B | A- | ||
+49.25% | 24.02B | A- | ||
+13.23% | 21.83B | A | ||
-1.52% | 18.77B | B- | ||
+28.90% | 16.76B | B | ||
-13.27% | 15.28B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PNDX B Stock
- Ratings Pandox AB